These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1098 related articles for article (PubMed ID: 10022415)
1. Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. Olivecrona H; Hilding A; Ekström C; Barle H; Nyberg B; Möller C; Delhanty PJ; Baxter RC; Angelin B; Ekström TJ; Tally M J Clin Endocrinol Metab; 1999 Feb; 84(2):553-60. PubMed ID: 10022415 [TBL] [Abstract][Full Text] [Related]
2. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659 [TBL] [Abstract][Full Text] [Related]
3. IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. Zhou X; Loke KY; Pillai CC; How HK; Yap HK; Lee KO Eur J Endocrinol; 2001 Mar; 144(3):237-43. PubMed ID: 11248742 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated. Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799 [TBL] [Abstract][Full Text] [Related]
5. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. Arosio M; Garrone S; Bruzzi P; Faglia G; Minuto F; Barreca A J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491 [TBL] [Abstract][Full Text] [Related]
7. Gene expression and serum levels of insulin-like growth factors (IGFs) and IGF-binding proteins in a case of non-islet cell tumour hypoglycaemia. Holt RI; Teale JD; Jones JS; Quin JD; McGregor AM; Miell JP Growth Horm IGF Res; 1998 Dec; 8(6):447-54. PubMed ID: 10985756 [TBL] [Abstract][Full Text] [Related]
8. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. Han VK; Bassett N; Walton J; Challis JR J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597 [TBL] [Abstract][Full Text] [Related]
9. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT. Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837 [TBL] [Abstract][Full Text] [Related]
10. Modifications of growth velocity and the insulin-like growth factor system in children with acute lymphoblastic leukemia: a longitudinal study. Argüelles B; Barrios V; Pozo J; Muñoz MT; Argente J J Clin Endocrinol Metab; 2000 Nov; 85(11):4087-92. PubMed ID: 11095437 [TBL] [Abstract][Full Text] [Related]
11. Effects of GH and/or sex steroids on circulating IGF-I and IGFBPs in healthy, aged women and men. Münzer T; Rosen CJ; Harman SM; Pabst KM; St Clair C; Sorkin JD; Blackman MR Am J Physiol Endocrinol Metab; 2006 May; 290(5):E1006-13. PubMed ID: 16390864 [TBL] [Abstract][Full Text] [Related]
12. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [TBL] [Abstract][Full Text] [Related]
13. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029 [TBL] [Abstract][Full Text] [Related]
16. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
17. Effects of fasting on IGF-I, IGF-II, and IGF-binding protein mRNA concentrations in channel catfish (Ictalurus punctatus). Peterson BC; Waldbieser GC Domest Anim Endocrinol; 2009 Aug; 37(2):74-83. PubMed ID: 19446983 [TBL] [Abstract][Full Text] [Related]
18. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P; Zwimpfer C; Zapf J; Schmid C Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465 [TBL] [Abstract][Full Text] [Related]
19. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. Wallace JD; Cuneo RC; Baxter R; Orskov H; Keay N; Pentecost C; Dall R; Rosén T; Jørgensen JO; Cittadini A; Longobardi S; Sacca L; Christiansen JS; Bengtsson BA; Sönksen PH J Clin Endocrinol Metab; 1999 Oct; 84(10):3591-601. PubMed ID: 10523001 [TBL] [Abstract][Full Text] [Related]
20. Stimulation of the 150-kilodalton insulin-like growth factor-binding protein-3 ternary complex by continuous and pulsatile patterns of growth hormone (GH) administration in GH-deficient patients. Laursen T; Flyvbjerg A; Jørgensen JO; Baxter RC; Christiansen JS J Clin Endocrinol Metab; 2000 Nov; 85(11):4310-4. PubMed ID: 11095473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]